-
-
-
-
-
-
-
IPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025
-
-
-
-
-
-
-
Immunoprecise Antibodies Ltd. (IPA) PT Lowered to $3 at Benchmark
-
-
-
-
-
-
-
ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms
-
-
-
-
-
-
-
IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024
-
-
-
-
-
-
-
IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023 on December 15, 2022
-
-
-
-
-
-
-
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2022
-
-
-
-
-
-
-
ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

